Filing Details
- Accession Number:
- 0001567619-20-016844
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-17 17:36:49
- Reporting Period:
- 2020-09-15
- Accepted Time:
- 2020-09-17 17:36:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1444380 | Nevro Corp | NVRO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1174533 | F Michael Demane | C/O Nevro Corp. 1800 Bridge Parkway Redwood City CA 94065 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-09-15 | 2,000 | $145.27 | 273,468 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-16 | 5,002 | $145.53 | 268,466 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-16 | 5,977 | $146.59 | 262,489 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-16 | 4,169 | $147.41 | 258,320 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-16 | 880 | $148.19 | 257,440 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 38,054 | Indirect | See footnote |
| Common Stock | 21,800 | Indirect | See footnote |
| Common Stock | 30,218 | Indirect | See footnote |
| Common Stock | 47,982 | Indirect | See footnote |
Footnotes
- The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $145.00 to $145.85, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- Includes 1,376 restricted stock units.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $145.04 to $146.00, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $146.07 to $147.05, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $147.07 to $148.05, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $148.07 to $148.36, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
- Shares held by Michael DeMane Trustee, Michael F. DeMane 2016 Retailed Annuity Trust U/A/D May 22, 2017.
- Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2018 Retained Annuity Trust 07/16/2018.
- Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees Michael F. DeMane Revocable Trust 10/07/2011.
Billionaire Hedge Funds
